Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Wally Mastroly who wrote (2374)	5/11/1998 2:34:00 PM
From: MARIO PASQUA	Respond to of 9523

Hi all, A friend called me from Europe (Italy to be specific) He said that they can't keep up with the demand. Selling for $18.00 per pill. IMHO PFE will be $160.00 per share in few weeks. Thereafter split 1 for 2 in the near future. -------------------------------- Pfizer's Viagra Gets 600,000 Prescriptions in April By Kerry Dooley New York: Pfizer Inc.'s Viagra had almost 600,000 prescriptions filled in April, its first month on the market, leading some analysts to predict sales of the impotence pill could rise as high as $2 billion in 1999. About 250,000 prescriptions were filled for Viagra in the week ended May 1, a 20 percent gain over the previous week, according to NDC Health Information Services, which tracks sales at pharmacies. Viagra's first-month sales were unprecedented, NDC said. Pfizer's stock has more than doubled in the past year on prospects for Viagra, a pill competing with less convenient impotence treatments. Better- than-expected early Viagra sales let Pfizer overtake rival Merck & Co. last month as the most valuable U.S. drug company. It reached an all-time high of 121 3/4 on April 21. ''Obviously, the first quarter (of Viagra sales) is going to be phenomenal,'' said Alex Zisson, an analyst with Hambrecht & Quist. ''The question is what the second quarter will be.'' Pfizer rose 3 11/16 to 110 9/16 in late trading.